Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/33044
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHiggins, Victoria-
dc.contributor.authorAdeli, Khosrow-
dc.date.accessioned2023-06-15T07:44:23Z-
dc.date.available2023-06-15T07:44:23Z-
dc.date.issued2019-01-
dc.identifier.citationÖzarda, Y. vd. (2019). ''Verification of reference intervals in routine clinical laboratories: Practical challenges and recommendations''. Clinical Chemistry and Laboratory Medicine, 57(1), Special Issue, 30-37.en_US
dc.identifier.issn1434-6621-
dc.identifier.issn1437-4331-
dc.identifier.urihttps://doi.org/10.1515/cclm-2018-0059-
dc.identifier.urihttps://www.degruyter.com/document/doi/10.1515/cclm-2018-0059/html-
dc.identifier.urihttp://hdl.handle.net/11452/33044-
dc.description.abstractReference intervals (RIs) are fundamental tools used by healthcare and laboratory professionals to interpret patient laboratory test results, ideally enabling differentiation of healthy and unhealthy individuals. Under optimal conditions, a laboratory should perform its own RI study to establish RIs specific for its method and local population. However, the process of developing RIs is often beyond the capabilities of an individual laboratory due to the complex, expensive and time-consuming process to develop them. Therefore, a laboratory can alternatively verify RIs established by an external source. Common RIs can be established by large, multicenter studies and can subsequently be received by local laboratories using various verification procedures. The standard approach to verify RIs recommended by the Clinical Laboratory Standards Institute (CLSI) EP28-A3c guideline for routine clinical laboratories is to collect and analyze a minimum of 20 samples from healthy subjects from the local population. Alternatively, "data mining" techniques using large amounts of patient test results can be used to verify RIs, considering both the laboratory method and local population. Although procedures for verifying RIs in the literature and guidelines are clear in theory, gaps remain for the implementation of these procedures in routine clinical laboratories. Pediatric and geriatric age-groups also continue to pose additional challenges in respect of acquiring and verifying RIs. In this article, we review the current guidelines/approaches and challenges to RI verification and provide a practical guide for routine implementation in clinical laboratories.en_US
dc.language.isoenen_US
dc.publisherWalter de Gruyterde
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectMedical laboratory technologyen_US
dc.subjectClinical laboratoriesen_US
dc.subjectCLSI EP28-A3c guidelineen_US
dc.subjectData miningen_US
dc.subjectReference intervalsen_US
dc.subjectVerificationen_US
dc.subjectPediatric reference intervalsen_US
dc.subjectGeriatric ages establishmenten_US
dc.subjectAdult reference intervalsen_US
dc.subjectSpecial chemistry biomarkersen_US
dc.subjectReference valuesen_US
dc.subjectWorldwide multicenteren_US
dc.subjectBiochemical markersen_US
dc.subjectGlobal multicenteren_US
dc.subjectCaliper databaseen_US
dc.subjectHealthyen_US
dc.subject.meshClinical chemistry testsen_US
dc.subject.meshData Miningen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshLaboratoriesen_US
dc.subject.meshMaleen_US
dc.subject.meshReference standardsen_US
dc.titleVerification of reference intervals in routine clinical laboratories: Practical challenges and recommendationsen_US
dc.typeArticleen_US
dc.identifier.wos000451633000004tr_TR
dc.identifier.scopus2-s2.0-85046969642tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Temel Tıp Bilimleri Bölümü.tr_TR
dc.identifier.startpage30tr_TR
dc.identifier.endpage37tr_TR
dc.identifier.volume57tr_TR
dc.identifier.issue1, Special Issueen_US
dc.relation.journalClinical Chemistry and Laboratory Medicineen_US
dc.contributor.buuauthorÖzarda, Yeşim-
dc.contributor.researcheridAAL-8873-2021tr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.relation.collaborationSanayitr_TR
dc.identifier.pubmed29729142tr_TR
dc.subject.wosMedical laboratory technologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ1en_US
dc.contributor.scopusid35741320500tr_TR
dc.subject.scopusClinical Chemistry; Thyrotropin; Chemical Speciesen_US
dc.subject.emtreeClinical laboratoryen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMulticenter study (topic)en_US
dc.subject.emtreePractice guidelineen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeReference valueen_US
dc.subject.emtreeReviewen_US
dc.subject.emtreeClinical chemistryen_US
dc.subject.emtreeData miningen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeLaboratoryen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeStandarden_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Özarda_vd_2019.pdf110.42 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons